196 related articles for article (PubMed ID: 7695265)
1. Possible implications of doxycycline-rifampin interaction for treatment of brucellosis.
Colmenero JD; Fernández-Gallardo LC; Agúndez JA; Sedeño J; Benítez J; Valverde E
Antimicrob Agents Chemother; 1994 Dec; 38(12):2798-802. PubMed ID: 7695265
[TBL] [Abstract][Full Text] [Related]
2. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis.
Colmenero Castillo JD; Hernandez Marquez S; Reguera Iglesias JM; Cabrera Franquelo F; Rius Diaz F; Alonso A
Chemotherapy; 1989; 35(2):146-52. PubMed ID: 2667903
[TBL] [Abstract][Full Text] [Related]
3. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis.
Ariza J; Gudiol F; Pallarés R; Rufí G; Fernández-Viladrich P
Antimicrob Agents Chemother; 1985 Oct; 28(4):548-51. PubMed ID: 4073878
[TBL] [Abstract][Full Text] [Related]
4. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study.
Ariza J; Gudiol F; Pallares R; Viladrich PF; Rufi G; Corredoira J; Miravitlles MR
Ann Intern Med; 1992 Jul; 117(1):25-30. PubMed ID: 1596044
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.
Solera J; Rodríguez-Zapata M; Geijo P; Largo J; Paulino J; Sáez L; Martínez-Alfaro E; Sánchez L; Sepulveda MA; Ruiz-Ribó MD
Antimicrob Agents Chemother; 1995 Sep; 39(9):2061-7. PubMed ID: 8540716
[TBL] [Abstract][Full Text] [Related]
6. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
[TBL] [Abstract][Full Text] [Related]
7. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
[TBL] [Abstract][Full Text] [Related]
8. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
Mile B; Valerija K; Krsto G; Ivan V; Ilir D; Nikola L
Trop Doct; 2012 Jan; 42(1):13-7. PubMed ID: 22290107
[TBL] [Abstract][Full Text] [Related]
9. [A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].
Solera J; Medrano F; Rodríguez M; Geijo P; Paulino J
Med Clin (Barc); 1991 May; 96(17):649-53. PubMed ID: 1905372
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].
Alp E; Koc RK; Durak AC; Yildiz O; Aygen B; Sumerkan B; Doganay M
BMC Infect Dis; 2006 Apr; 6():72. PubMed ID: 16606473
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of brucellosis with rifampicin and doxycycline].
Garcés JM; Verdaguer A; Gutiérrez-Cebollada J; Tàpies A; Drobnic L
Rev Clin Esp; 1987 Apr; 180(7):372-4. PubMed ID: 3602550
[No Abstract] [Full Text] [Related]
12. Efficacy of combinations of doxycycline and rifampicin in the therapy of experimental mouse brucellosis.
Shasha B; Lang R; Rubinstein E
J Antimicrob Chemother; 1994 Mar; 33(3):545-51. PubMed ID: 8040118
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis.
Roushan MR; Gangi SM; Ahmadi SA
Swiss Med Wkly; 2004 Sep; 134(37-38):564-8. PubMed ID: 15551160
[TBL] [Abstract][Full Text] [Related]
14. Treatment of human brucellosis.
Solera J
J Med Liban; 2000; 48(4):255-63. PubMed ID: 11214198
[TBL] [Abstract][Full Text] [Related]
15. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A
Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of two regimens in the treatment of brucellosis.
Rodriguez Zapata M; Gamo Herranz A; De La Morena Fernández J
Chemioterapia; 1987 Jun; 6(2 Suppl):360-2. PubMed ID: 3334575
[No Abstract] [Full Text] [Related]
17. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
Karabay O; Sencan I; Kayas D; Sahin I
BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
[TBL] [Abstract][Full Text] [Related]
18. A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis.
Keramat F; Ranjbar M; Mamani M; Hashemi SH; Zeraati F
Trop Doct; 2009 Oct; 39(4):207-10. PubMed ID: 19762571
[TBL] [Abstract][Full Text] [Related]
19. A multicenter therapeutic study of 1100 children with brucellosis.
Lubani MM; Dudin KI; Sharda DC; Ndhar DS; Araj GF; Hafez HA; al-Saleh QA; Helin I; Salhi MM
Pediatr Infect Dis J; 1989 Feb; 8(2):75-8. PubMed ID: 2649867
[TBL] [Abstract][Full Text] [Related]
20. [Rifampicin and doxycycline in the treatment of brucellosis].
Garcés JM
Med Clin (Barc); 1991 Nov; 97(17):678-9. PubMed ID: 1762466
[No Abstract] [Full Text] [Related]
[Next] [New Search]
